Finance
Immunovant Inc [IMVT] is -21.46% lower this YTD. Is it still time to buy?
Immunovant Inc [NASDAQ: IMVT] traded at a high on Thursday, posting a 4.81 gain after which it closed the day’ session at $33.09. The company report on March 12, 2024 at 7:30 AM that Immunovant Awarded U.S. Patent for IMVT-1402. Composition of matter patent issued
